We use cookies to gather anonymous information about how our site is used.
If you continue using our site we'll assume that you are happy for the use of this cookie to continue.
Get in touch with us: 0800 085 6696 or

Prostate Cancer News

ProstateHealth UK’s Clinical Director is Mr Vincent Gnanapragasam who is an academic consultant urological surgeon at the University of Cambridge and Addenbrookes Hospital, Cambridge. This means that ProstateHealth UK is in touch with the latest sources of clinical data and news about prostate cancer and thus can provide you with highly relevant and accurate information about this disease and other prostate problems.

Please keep checking our prostate cancer news section for the latest information and, if you have any questions, please don’t hesitate to contact us.

May, 2016

A new survey carried out by a leading prostate cancer charity has revealed a serious lack of awareness among men about their own bodies and their risk of prostate cancer, despite the fact that one man every hour dies from the disease.

The research carried out by Prostate Cancer UK, which surveyed almost 2,000 men, showed that most had no idea what the gland did or even that they had one. 92% of them did not know that the prostate helps make the fluid sperm swims in and contains muscles for ejaculation, whilst more than half did not know where it was in their body. 17% of those surveyed were unaware of it altogether.

September, 2015

Earlier this year, we reported on the new cancer task force, set up to combat long waiting times for diagnoses in England – 25% of which were being made too late. Now, further plans have been unveiled, including a target of 95% of people being given a diagnosis or the all-clear within 28 days of being referred by their GP, by 2020.

Figures released in May showed that more than 21,000 people had not been treated within 62 days of their cancer diagnosis in the last financial year, and the NHS had failed to achieve its own targets for treatment. According to these, 85% of cancer patients should be treated within 62 days of being urgently referred by their GP, but just 83.4% were seen on time in 2014-15. While survival rates have been improving, England still lags behind some of the best performing countries. A cross-party committee of MPs recently warned that England’s cancer services had “lost momentum”.

August, 2015

This week, the BBC reports on new research findings that demonstrate how even light consumption of alcohol can increase cancer risk – but the risk primarily affects women.

The US research, published in the British Medical Journal this month, is titled “Light to moderate intake of alcohol, drinking patterns, and risk of cancer” and sets out “to quantify risk of overall cancer across all levels of alcohol consumption among women and men separately, with a focus on light to moderate drinking and never smokers; and assess the influence of drinking patterns on overall cancer risk.”

August, 2015

A new study has revealed that almost a quarter of cancer patients had to make at least three visits to their GP before being sent to hospital for tests that diagnosed their illness.

The research – published in the European Journal of Cancer Care – was undertaken by academics at Cambridge University who studied the experiences of more than 70,000 patients. They found that a total of 23% had been seen by their GP three or more times before being referred to hospital for further scans, blood tests or investigations which diagnosed the illness.

July, 2015

Cancer Research UK scientists have for the first time identified that there are five distinct types of prostate cancer and found a way to distinguish between them, according to a landmark study published in EbioMedicine.

The findings could have important implications for how doctors treat prostate cancer in the future, by identifying tumours that are more likely to grow and spread aggressively through the body.

July, 2015

This week, Sarah Montague – a night-time presenter for the BBC – investigated the impact of shift work on health, and found that regular disruption of normal sleep patterns can significantly raise your susceptibility to serious illness, including cancer.

In the programme The Night Shift, broadcast on BBC Radio 4 onMonday 27 July,8.00pm-8.30pm, Sarah Montague, explored how sleeping affects our bodies in the company of two fellow night-workers.

June, 2015

The results of a new study have established a link between prostate cancer and smoking, reports Science Daily.

Smoking has long been known to contribute to the risk of developing a variety of forms of cancer, but this is the first time a clear link has been established with prostate cancer. The link is not with the initial development of prostate cancer, however, but its recurrence following treatment.

March 2015: is Prostate Cancer Awareness Month, and amongst the many activities organised to help raise awareness of this specifically male cancer Macmillan are hosting a live prostate webchat on their website. But how much do you already know about your prostate?

February 2015: This week saw a BBC news report on cancer that contained shocking news for the UK. ‘Half of UK people will get cancer’ revealed that one in two people in the UK will be diagnosed with cancer at some point in their lives.

January 2015: Check4Cancer Ltd (Check4Cancer) is pleased to announce the appointment of three new company employees across its Client Service, Marketing and Finance divisions. Cambridge based Check4Cancer has appointed Lene Farmer as Client Services Manager, Indre Peciunaityte as Marketing Manager and Reka Fogarasi as Finance Assistant.

14 November 2014: A multicentre research study has confirmed that 4Kscore blood test has excellent ability to identify men likely to have significant (high-grade) prostate cancer, while reducing the number of unnecessary biopsies. This study of 1012 men scheduled to have a prostate biopsy, is the first non-European research study to validate the blood test that measures four kallikreins in human blood (4Kscore), with the authors reporting a 30-58% reduction in unnecessary biopsies depending on the cut-off used.

Updated results of the ERSPC trial affirm the benefits of prostate cancer screening in reducing death but open opportunities for new screening tools.

August 2014: By Vincent J Gnanapragasam Addenbrookes Hospital, Cambridge

The recent publication of the updated European Randomized study of Screening for Prostate Cancer trial has again ignited the debate on the benefits of screening for prostate cancer. What we can clearly say is that a screening programme does reduce mortality from prostate cancer.

November 2013: OPKO Health, Inc. commences a pivotal, multi-center clinical validation study for the company’s proprietary 4Kscore™ test for the prediction of prostate cancer prior to prostate biopsy. The 4Kscore™ test is based on over a decade of research of a four kallikrein panel of biomarkers conducted by scientists at Memorial Sloan Kettering Cancer Center and leading research centers in Europe on over 10,000 patients. It is believed that the test will address a significant need for better tests to identify men at risk for aggressive prostate cancer, while at the same time avoiding unnecessary, costly, and potentially harmful treatments.

Read More

August 2013: A donation of £1,500 is hoped to be the first of many in the continued corporate support of prostate cancer charity The Graham Fulford Charitable Trust. Both organisations are keen to educate 'at risk' groups such as those men with strong family history of either prostate cancer or breast cancer and this donation should help with ongoing campaigns to do just that. 

February 2013:ProstateHealth UK have decided to support the excellent work of the Graham Fulford Charitable Trust who is focused on increasing awareness of prostate cancer and the invaluable effect of early detection. View their website to read about some of the excellent work they do.

23th Oct 2012:Delegates from leading employers, health insurers and employee benefit consultancies attended the launch of ProstateCheck and LungCheck. Here is a summary of the event with some interesting feedback and quotes from attendees.

Read more: Summary Report

16th October 2012: Daily Mail article: Flaws in the usual test lead to needless ops that can wreck sex lives

Read more: Daily Mail

21st March 2012: It has been known for a number of years now that prostate cancer deaths can be reduced by PSA testing

28th January 2012: Thousands of men with prostate cancer are being "forgotten" because it is still regarded as an "old man's disease"

Read more from the Telegraph here

16th November 2011:Rise in prostate cancer 'due to use of the Pill which increases men's exposure to oestrogen'

Read more: From the Daily Mail

15th November 2011: Why we all need to talk about prostate cancer the forgotten cancer

Read more: From the The Telegraph

ProstateGene
If you are worried about prostate cancer due to your father or grand father being diagnosed with it click the icon above
HealthInvestor Awards 2016 logo HealthInvestor Awards 2017 logo
ProstateHealth UK is regulated by the Care Quality Commission
© 2017 ProstateHealth UK, 1 The Mill, Copley Hill Business Park, Cambridge Road, Cambridge CB22 3GN - Registered in England and Wales. Company registration number 08866941
All data send on this website is encrypted (SSL).